Diagnostics and treatment of the diabetic foot

Endocrine

Volumn 41, Issue 3, 2012, Pages 384-397

  Apelqvist, Jan ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Diabetic foot; Foot ulcer; Infection; Ischemia; Revascularisation; Treatment

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; OXYGEN; SULTAMICILLIN;

ANTIBIOTIC THERAPY; CLINICAL EXAMINATION; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEBRIDEMENT; DETERIORATION; DIABETIC FOOT; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; ECHOGRAPHY; EDEMA; FOOT MALFORMATION; FOOT SURGERY; GANGRENE; HUMAN; HYPERBARIC OXYGEN; INFECTION; INFLAMMATION; LEG AMPUTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALNUTRITION; METABOLIC DISORDER; PAIN; PERFUSION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; VACUUM ASSISTED CLOSURE; WEIGHT BEARING; WOUND DRESSING; WOUND HEALING;

EID: 84862662213     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9619-x     Document Type: Review

References (186)

1. A.J. Boulton, L. Vileikyte, G. Ragnarson-Tennvall, J. Apelqvist, The global burden of diabetic foot disease. Lancet 366(9498), 1719-1724 (2005) (Pubitemid 41587452)
2. International Working Group on the Diabetic Foot, International consensus on the diabetic foot and practical guidelines on the management and the prevention of the diabetic foot. Amsterdam, the Netherlands (2011). Available on CD-ROM at www.idf.org/bookshop or (www.diabeticfoot.nl)
3. J. Apelqvist, K. Bakker, W.H. van Houtum, International Working Group on the Diabetic Foot (IWGDF) Editorial Board, Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev. 24(Suppl 1), S181-S187 (2008)
4. S. Tesfaye, A.J.M. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler et al., Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10), 2285-2293 (2010)
5. E.J. Boyko, J.H. Ahtoni, V. Stensel, R.C. Forsberg, D.R. Davignon, D.G. Smith, A prospecticve study for risk factors for diabetic ulcer. The Seattle Diabetic Foot Study. Diabetes Care 22, 1036-1042 (1999) (Pubitemid 29293951)
6. C.A. Abbott, A.L. Carrington, H. Ashe, S. Bath, L.C. Every, J. Griffiths et al., The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet. Med. 19, 377-384 (2002) (Pubitemid 34534212)
7. N. Singh, D.G. Amstrong, B.A. Lipsky, Preventing foot ulcers in patients with diabetes. JAMA 293, 217-228 (2005) (Pubitemid 40095873)
8. E.J. Boyko, J.H. Ahroni, V. Cohen, K.M. Nelson, P.J. Heagerty, Prediction of diabetic ulcer occurrence using commonly available clinical information. The Seattle Diabetic Foot Study. Diabetes Care 29, 1202-1207 (2006) (Pubitemid 44125910)
9. A.J. Boulton, The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab. Res. Rev. 24(Suppl 1), S3-S6 (2008) (Pubitemid 351802764)
10. J. Apelqvist, J. Larsson, What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab. Res. Rev. 16(Suppl 1), S75-S83 (2000)
11. W. Jeffcoate, F. Game, P. Cavanagh, The role of proinflammatory cytokines in the cause of neuropathic osteoartropathy (acute Charcot foot) in diabetes. Lancet 366, 2058-2061 (2005) (Pubitemid 41773381)
12. E. Trepman, A. Nihal, M. Pinzur, Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 26, 46-63 (2005)
13. L. Prompers, N. Schaper, J. Apelqvist, M. Edmonds, E. Jude, D. Mauricio et al., Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51(5), 747-755 (2008)
14. L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G. Ragnarson Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. van Baal, F. van Merode, High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50, 18-25 (2007) (Pubitemid 46035847)
15. L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G.R. Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. Van Baal, F. Van Merode, N. Schaper, Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study. Diabet. Med. 25, 700-707 (2008) (Pubitemid 351782831)
16. M.A. Gershater, M. Löndahl, P. Nyberg, J. Larsson, J. Thörne, M. Eneroth, J. Apelqvist, Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52(3), 398-407 (2009)
17. N.C. Schaper, M.H. Nabuurs-Franssen, S.P. Huijberts, Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 16(Suppl 1), S11-S15 (2000)
18. F.W. LoGerfo, J.D. Coffman, Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N. Engl. J. Med. 311, 1615-1619 (1984) (Pubitemid 15175203)
19. G. Jörneskog, K. Brismar, B. Fagrell, Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic control. Diabetologia 41(4), 410-415 (1998) (Pubitemid 28157411)
20. N.C. Schaper, M. Huijberts, K. Pickwell, Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab. Res. Rev. 24(suppl 1), S40-S44 (2008) (Pubitemid 351802771)
21. M.S. Ruiter, J.M. van Golde, N.C. Schaper, C.D. Stehouwer, M.S. Huijberts, Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin. Sci. (Lond.) 119(6), 225-238 (2010)
22. C. Gazzaruso, A. Coppola, M. Montalcini, E. Baffero, A. Garzaniti, G.G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41, 89-95 (2012)
23. L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker et al., Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study. Int. J. Low Extrem. Wounds 6(1), 11-17 (2007)
24. S. Krishnan, F. Nash, N. Baker, D. Fowler, G. Rayman, Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 31, 99-101 (2008)
25. W.H. van Houtum, J.A. Rauwerda, D. Ruwaard, N.C. Schaper, K. Bakker, Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991-2000. Diabetes Care 27, 1042-1046 (2004) (Pubitemid 38579763)
26. J. Larsson, J. Apelqvist, C.D. Agardh, A. Stenström, Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet. Med. 12, 770-776 (1995)
27. K. Aydin, M. Isildak, J. Karakaya, A. Gurlek, Change in amputation predictors in diabetic foot disease: effect of multidisciplinary approach. Endocrine 38, 87-92 (2010)
28. M. Luther, I. Kantonen, M. Lepantalo, FINNVASC Study Group, Arterial intervention and reduction in amputation for chronic critical leg ischaemia. Br. J. Surg. 87, 454-458 (2000) (Pubitemid 30192956)
29. H. Zayed, M. Halawa, L. Maillardet, P.S. Sidhu, M. Edmonds, H. Rashid, Improving limb salvage rate in diabetic patients with critical leg ischaemia using a multidisciplinary approach. Int. J. Clin. Pract. 63(6), 855 (2009)
30. A.J.M. Boulton, The diabetic foot: from art to science. Diabetologia 47(8), 1343-1353 (2004)
31. International Working Group on the Diabetic Foot (IWGDF) Editorial Board, The diabetic foot. Diabetes Metab. Res. Rev. 24(Suppl 1), S1-S193 (2008)
32. P.R. Cavanagh, B.A. Lipsky, A.W. Bradbury, G. Botek, Treatment for diabetic foot ulcers. Lancet 366(9498), 1725-1735 (2005) (Pubitemid 41587453)
33. J. Kalish, A. Hamdan, Management of diabetic foot problems. J. Vasc. Surg. 51(2), 476-486 (2010)
34. J. Apelqvist, The foot in perspective. Diabetes Metab. Res. Rev. 24(Suppl 1), S110-S115 (2008) (Pubitemid 351802783)
35. D. Steed, C. Attinger, T. Colaizzi, M. Crossland, M. Franz, L. Harkless et al., Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 14, 680-692 (2006) (Pubitemid 44951308)
36. S. Vuorisalo, M. Venermo, M. Lepäntalo, Treatment of diabetic foot ulcers. J. Cardiovasc. Surg. 50(3), 275-291 (2009)
37. R. Fontaine, M. Kim, R. Kieny, Surgical treatment of peripheral circulation disorders. Helv. Chir. Acta 21, 499-533 (1954)
38. P.R.F. Bell, D. Charlesworth, R.G. DePalma, H.H.G. Eastcott, B. Eklöf, J.D. Gruss, C.W. Jamieson, P.J. Morris, A.N. Nicolaides, R.B. Rutherford, The definition of critical iscaemia of a limb. Br. J. Surg. 69, 22 (1982)
39. Suggested standards for reports dealing with lower extremity ischemia, Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 4(1), 80-94 (1986)
40. Second European consensus document on chronic critical leg ischaemia. Eur. J. Vasc. Surg. 6(suppl A), 1-32 (1992)
41. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, S. Ahn, D.N. Jones, Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 26(3), 517-538 (1997) (Pubitemid 27408567)
42. L. Norgren, W.R. Hiatt, J.A. Dormandy, on behalf of the TASC II Working Group, Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45(Suppl), S5-S67 (2007) (Pubitemid 46151680)
43. Management of peripheral arterial disease (PAD), Transatlantic inter-society consensus (TASC). Eur. J. Vasc. Endovasc. Surg. 19(Suppl A), S1-S250 (2000)
44. N.C. Schaper, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab. Res. Rev. 20(Suppl 1), 90-95 (2004)
45. D.G. Armstrong, L.A. Lavery, L.B. Harkless, Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21(5), 855-859 (1998) (Pubitemid 28487086)
46. S. Beckert, M. Witte, C. Wicke et al., A new wound-based severity score for diabetic foot ulcers. Diabetes Care 29(5), 988-992 (2006)
47. N.C. Schaper, G. Andros, J. Apelqvist, K. Bakker, J. Lammer, M. Lepantalo, J.L. Mills, J. Reekers, C.P. Shearman, R.E. Zierler, R.J. Hinchliffe, Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev. 28(Suppl 1), 218-224 (2012)
48. S.R. McGee, E.J. Boyko, Physical examination and chronic lower-extremity ischemia: a critical review. Arch. Intern. Med. 158(12), 1357 (1998)
49. N.C. Schaper, G. Andros, J. Apelqvist, K. Bakker, J. Lammer, M. Lepantalo, J.L. Mills, J. Reekers, C.P. Shearman, R.E. Zierler, R.J. Hinchliffe, Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot. Diabetes Metab. Res. Rev. 28(Suppl 1), 236-237 (2012)
50. M. Lundin, J.P. Wiksten, T. Peräkylä, O. Lindfors, H. Savolainen, J. Skyttä et al., Distal pulse palpation: is it reliable? World J. Surg. 23, 252-255 (1999) (Pubitemid 29091693)
51. J. Apelqvist, J. Larsson, C.-D. Agardh, The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabet. Med. 7, 590-594 (1990) (Pubitemid 20229734)
52. G. Andros, R.W. Harris, L.B. Dulawa, R.W. Oblath, S.X. Salles-Cunha, The need for arteriography in diabetic patients with gangrene and palpable foot pulses. Arch. Surg. 119(11), 1260-1263 (1984) (Pubitemid 15182196)
53. E.J. Boyko, J.H. Ahroni, D. Davignon, V. Stensel, R.L. Prigeon, D.G. Smith, Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. J. Clin. Epidemiol. 50(6), 659-668 (1997) (Pubitemid 27341816)
54. A.M. O'Hare, R. Katz, M.G. Shilipak, M. Cushman, A.B. Newman, Mortality and cardiovascular risk across ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113, 388-393 (2006) (Pubitemid 43803200)
55. V. Aboyans, E. Ho, J.O. Denenberg, L.A. Ho, L. Natarajan, M.H. Criqui, The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J. Vasc. Surg. 48, 1197-1203 (2008)
56. J. Apelqvist, J. Castenfors, J. Larsson, A. Stenstrom, C.D. Agardh, Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12, 373-378 (1989) (Pubitemid 19140655)
57. P. Holstein, The distal blood pressure predicts healing of amputations on the feet. Acta Orthop. Scand. 55, 227-233 (1984) (Pubitemid 14166387)
58. J.L. Ballard, C.C. Eke, T.J. Bunt, J.D. Killeen, A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. J. Vasc. Surg. 22, 485-490 (1995)
59. E. Faglia, G. Clerici, M. Caminiti, A. Quarantiello, V. Curci, A. Morabito, Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia. Eur. J. Vasc. Endovasc. Surg. 33, 731-736 (2007) (Pubitemid 46672819)
60. E. Lukkari-Rautiarinen, M. Lepäntalo, J. Pietilä, Reproducibility of skin blood flow, perfusion pressure and oxygen tension measurements in advanced lower limb ischaemia. Eur. J. Vasc. Surg. 3, 345-350 (1989) (Pubitemid 19279974)
61. M.S. Pinzur, R. Stuck, R. Sage, H. Osterman, Transcutaneous oxygen tension in the dysvascular foot with infection. Foot Ankle 14, 254-256 (1993) (Pubitemid 23182191)
62. E.J. Boyko, J.H. Ahroni, V.L. Stensel, D.G. Smith, D.R. Davignon, R.E. Pecoraro, Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects. Diabet. Med. 13, 549-554 (1996) (Pubitemid 26201508)
63. W.B. Kannel, D.L. McGee, Update on some epidemiologic features of intermittent claudication: the Framingham Study. J. Am. Geriatr. Soc. 33(1), 13-18 (1985) (Pubitemid 15153432)
64. W.A. Marston, S.W. Davies, B. Armstrong, M.A. Farber, R.C. Mendes, J.J. Fulton et al., Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J. Vasc. Surg. 44(1), 108-114 (2006)
65. A. Karthikesalingam, P.J. Holt, P. Moxey, K.G. Jones, M.M. Thompson, R.J. Hinchliffe, A systematic review of scoring systems for diabetic foot ulcers. Diabet. Med. 27(5), 544-549 (2010)
66. J.K. Raines, R.C. Darling, J. Buth, D.C. Brewster, W.G. Austen, Vascular laboratory criteria for the management of peripheral vascular disease of the lower extremities. Surgery 79, 21-29 (1976)
67. R. Takolander, J.A. Rauwerda, The use of noninvasive vascular assessment in diabetic patients with foot lesions. Diabet. Med. 13(suppl 1), S39-S42 (1995)
68. G.L. Moneta, R.A. Yeager, R.W. Lee, J.M. Porter, Noninvasive localization of arterial occlusive disease: a comparison of segmental Doppler pressures and arterial duplex mapping. J. Vasc. Surg. 17, 578-582 (1993) (Pubitemid 23095535)
69. F.T. Padberg, T.L. Back, P.N. Thompson, R.W. Hobson II, Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity. J. Surg. Res. 60, 365-369 (1996) (Pubitemid 26062993)
70. L. Graziani, A. Silvestro, V. Bertone, E. Manara, R. Andreini, A. Sigala, R. Mingardi, R. De Giglio, Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg. 33(4), 453-460 (2007) (Pubitemid 46349954)
71. K.A. Arsenault, J. McDonald, P.J. Devereaux, K. Thorlund, J.G. Tittley, R.P. Whitlock, The use of transcutaneous oximetry to predict complications of chronic wound healing: a systematic review and meta-analysis. Wound Repair Regen. 19, 657-663 (2011)
72. J.L. Mills Sr, Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischaemia. Diabetes Metab. Res. Rev. 24(Suppl 1), S34-S39 (2008) (Pubitemid 351802770)
73. F. Pomposelli, Arterial imaging in patients with lower extremity ischemia and diabetes mellitus. J. Vasc. Surg. 52(3 Suppl), 81S- 91S (2010)
74. R. Collins, J. Burch, G. Cranny, R. Aguiar-Ibáñez, D. Craig, K. Wright, E. Berry, M. Gough, J. Kleijnen, M. Westwood, Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 334(7606), 1257 (2007)
75. R. Met, S. Bipat, D.A. Legemate, J.A. Reekers, M.J. Koelemay, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and metaanalysis. JAMA 301, 415-424 (2009)
76. M.H. Heijenbrok-Kal, M.C. Kock, M.G. Hunink, Lower extremity arterial disease: multidetector CT angiography metaanalysis. Radiology 245, 433-439 (2007) (Pubitemid 47612524)
77. D.J. Dinter, K.W. Neff, G. Visciani, R. Lachmann, C. Weiss, S.O. Schoenberg, H.J. Michaely, Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels - A combined retrospective and prospective study. AJR Am. J. Roentgenol. 193, 234-240 (2009)
78. G. Andreisek, T. Pfammatter, K. Goepfert, D. Nanz, P. Hervo, R. Koppensteiner, D. Weishaupt, Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 242, 610-620 (2007) (Pubitemid 46146213)
79. N. Diehm, A. Shang, A. Silvestro, D.D. Do, F. Dick, J. Schmidli, F. Mahler, I. Baumgartner, Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur. J. Vasc. Endovasc. Surg. 31(1), 59-63 (2006) (Pubitemid 43024985)
80. A. Ndip, L. Lavery, A.J.M. Boulton, Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr. Diabetes Rep. 10, 283-290 (2010)
81. M. Heikkinen, M. Salmenperä, A. Lepäntalo, M. Lepäntalo, Diabetes care for patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 33, 583-591 (2007) (Pubitemid 46552916)
82. M.R. Prince, H. Zhang, M. Morris, J.L. MacGregor, M.E. Grossman, J. Silberzweig, R.L. DeLapaz, H.J. Lee, C.M. Magro, A.M. Valeri, Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3), 807-816 (2008)
83. C. Rydahl, H.S. Thomsen, P. Marckmann, High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest. Radiol. 43(2), 141-144 (2008)
84. R. Wertman, E. Altun, D.R. Martin, D.G. Mitchell, J.R. Leyendecker, R.B. O'Malley, D.J. Parsons, E.R. Fuller 3rd, R.C. Semelka, Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 248(3), 799-806 (2008)
85. J. Apelqvist, T. Elgzyri, J. Larsson, M. Löndahl, P. Nyberg, J. Thörne, Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J. Vasc. Surg. 53(6), 1582-1588 (2011)
86. E. Faglia, G. Clerici, J. Clerissi, L. Gabrielli, S. Losa, M. Mantero, M. Caminiti, V. Curci, A. Quarantiello, T. Lupattelli, A. Morabito, Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 32(5), 822-827 (2009)
87. L. Uccioli, R. Gandini, L. Giurato, S. Fabiano, E. Pampana, V. Spallone, E. Vainieri, G. Simonetti, Long-term outcomes of diabetic patients with critical limb ischaemia followed in a tertiary referral diabetic foot clinic. Diabetes Care 33(5), 977-982 (2010)
88. Hinchliffe et al., A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab. Res. Rev. 28(Suppl 1), 179-217 (2012)
89. E. Faglia, G. Clerici, J. Clerissi, M. Mantero, M. Caminiti, A. Quarantiello et al., When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia? Diabet. Med. 24, 823-829 (2007) (Pubitemid 47096589)
90. F. Sigala, Ch. Menenakos, P. Sigalas, Ch. Baunach, S. Langer, E. Papalambros et al., Transluminal angioplasty of isolated crural arterial lesions in diabetics with critical limb ischemia. VASA 34, 186-191 (2005) (Pubitemid 41248257)
91. T. Zeller, S. Sixt, A. Rastan, New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia. VASA 38, 3-12 (2009)
92. H.H. Dosluoglu, G.S. Cherr, P. Lall, L.M. Harris, M.L. Dryjski, Peroneal artery-only runoff following endovascular revascularizations is effective for limb salvage in patients with tissue loss. J. Vasc. Surg. 48, 137-143 (2008)
93. E. Faglia, L. Dalla Paola, G. Clerici, J. Clerissi, L. Graziani, M. Fusaro, L. Gabrielli, S. Losa, A. Stella, M. Gargiulo, M. Mantero, M. Caminiti, S. Ninkovic, V. Curci, A. Morabito, Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur. J. Vasc. Endovasc. Surg. 29(6), 620-627 (2005) (Pubitemid 40626707)
94. L. Graziani, A. Piaggesi, Indications and clinical outcomes for below knee endovascular therapy: review article. Catheter. Cardiovasc. Interv. 75(3), 433-443 (2010)
95. M. Manzi, M. Fusaro, T. Ceccacci, G. Erente, L. Dalla Paola, E. Brocco, Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries. J. Cardiovasc. Surg. 50(3), 331-337 (2009)
96. D.M. Ihnat, J.L. Mills Sr, Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J. Vasc. Surg. 52(Suppl 3), 92S-95S (2010)
97. V.A. Alexandrescu, G. Hubermont, Y. Philips, B. Guillaumie, C. Ngongang, P. Vandenbossche, K. Azdad, G. Ledent, J. Horion, Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J. Endovasc. Ther. 15(5), 580-593 (2008)
98. C. Setacci, G. De Donato, F. Setacci, E. Chisci, Ischemic foot: definition, etiology and angiosome concept. J. Cardiovasc. Surg. 51(2), 223-231 (2010)
99. R.F. Neville, C.E. Attinger, E.J. Bulan, I. Ducic, M. Thomassen, A.N. Sidawy, Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann. Vasc. Surg. 23(3), 367-373 (2009)
100. C.E. Attinger, K.K. Evans, E. Bulan, P. Blume, P. Cooper, Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast. Reconstr. Surg. 117(7 Suppl), 261S-293S (2006) (Pubitemid 44317790)
101. M.I. Söderström, E.M. Arvela, M. Korhonen, K.H. Halmesmäki, A.N. Albäck, F. Biancari, M.J. Lepäntalo, M.A. Venermo, Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann. Surg. 252(5), 765-773 (2010)
102. R. Met, K.P. Van Lienden, M.J. Koelemay, S. Bipat, D.A. Legemate, J.A. Reekers, Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc. Interv. Radiol. 31, 687-697 (2008)
103. F.B. Pomposelli, N. Kansal, A.D. Hamdan, A. Belfield, M. Sheahan, D.R. Campbell, J.J. Skillman, F.W. Logerfo, A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J. Vasc. Surg. 37, 307-315 (2003) (Pubitemid 36236907)
104. M. Kalani, J. Apelqvist, M. Blombäck, K. Brismar, B. Eliasson, J.W. Eriksson et al., Effect of dalteparin on the healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care 26(9), 2575-2580 (2003) (Pubitemid 37052102)
105. M. Rullan, L. Cerda, G. Frontera, L. Masmiquel, J. Llobera, Treatment oc chronic diabetic foot ulcers with bemiparin a randomized, triple-blind, placebo controlled, clinical trial. Diabet. Med. 25(9), 1090-1095 (2008). Erratum in: Diabet. Med. 25(10), 1257 (2008)
106. M. Weck, H. Rietzsch, H. Lawall, U. Pichlmeier, P. Bramlage, S. Schellong, Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration. Thromb. Haemost. 100(3), 475-482 (2008)
107. R.J. Hinchliffe, G.D. Valk, J. Apelqvist, D.G. Armstrong, K. Bakker, F.L. Game et al., A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab. Res. Rev. 24(Suppl 1), S119-S144 (2008) (Pubitemid 351802785)
108. Game et al., A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab. Res. Rev. 28(Suppl 1), 119-141 (2012)
109. M. Eneroth, J. Larsson, J. Apelqvist, Foot infections in diabetes mellitus-entity with different characteristics, treatment and prognosis. J. Diabetes Complicat. 13(5-6), 254-263 (1999) (Pubitemid 30182605)
110. M. Eneroth, J. Apelqvist, Clinical characteristics and outcome in diabetic patients with deep foot infections. Foot Ankle 18, 716-722 (1997) (Pubitemid 27495298)
111. B.A. Lipsky, A.R. Berendt, J. Embil, F. de Lalla, Diagnosing and treating diabetic foot infections. Diabetes Metab. Res. Rev. 20(Suppl 1), S56-S64 (2004) (Pubitemid 38714338)
112. L.A. Lavery, D. Armstrong, R. Wunderlich, M. Mohler, C. Wendel, B. Lipsky, Risk factors for foot infections in individuals with diabetes. Diabetes Care 29, 1288-1293 (2006) (Pubitemid 44125924)
113. B.A. Lipsky, Y.P. Tabak, R.S. Johannes et al., Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 53, 914-923 (2010)
114. A.R. Berendt, E.J. Peters, K. Bakker, J.M. Embil, M. Eneroth, R.J. Hinchliffe, W.J. Jeffcoate, B.A. Lipsky, E. Senneville, J. Teh, G.D. Valk, Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab. Res. Rev. 24(Suppl 1), S145-S161 (2008) (Pubitemid 351802786)
115. S. Butalia, V.A. Palda, R.J. Sargeant, A.S. Detsky, O. Mourad, Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 299, 806-813 (2008) (Pubitemid 351281574)
116. National Institute for Health and Clinical Excellence, Diabetic foot-inpatient management of people with diabetic foot ulcers and infection (2011), http://guidance.nice.org.uk/CG119. 6/4/ 2011
117. G. Pellizer, M. Strazzabosco et al., Deep tissue biopsy vs superficial swap culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet. Med. 18, 822-827 (2001) (Pubitemid 32953789)
118. D.R. Graham, C. Lucasti, O. Malafaia, R.L. Nichols, P. Holtom, N.Q. Perez, A. McAdams, G.L. Woods, T.P. Ceesay, R. Gesser, Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, doubleblind multicenter study. Clin. Infect. Dis. 34(11), 1460-1468 (2002) (Pubitemid 34553705)
119. N. Saltoglu, A. Dalkiran, T. Tetiker, H. Bayram, Y. Tasova, C. Dalay, M. Sert, Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin. Microbiol. Infect. 16(8), 1252-1257 (2010)
120. D.R. Graham, D.A. Talan, R.L. Nichols, C. Lucasti, M. Corrado, N. Morgan, C.L. Fowler, Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillinclavulanate for complicated skin and skin-structure infections: a randomized, open-label trial. Clin. Infect. Dis. 35(4), 381-389 (2002) (Pubitemid 34852567)
121. B.A. Lipsky, K.J. Holroyd, M. Zasloff, Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin. Infect. Dis. 47(12), 1537-1545 (2008)
122. J.S. Tan, N.M. Friedman, C. Hazelton-Miller, J.P. Flanagan, T.M. File Jr, Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin. Infect. Dis. 23(2), 286-291 (1996) (Pubitemid 26264911)
123. A.D. Tice, R.S. Turpin, C.T. Hoey, B.A. Lipsky, J. Wu, M.A. Abramson, Comparative costs of ertapenem and piperacillintazobactam in the treatment of diabetic foot infections. Am. J. Health Syst. Pharm. 64(10), 1080-1086 (2007) (Pubitemid 46801540)
124. B.A. Lipsky, D.G. Armstrong, D.M. Citron, A.D. Tice, D.E. Morgenstern, M.A. Abramson, Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366(9498), 1695-1703 (2005) (Pubitemid 41587448)
125. P.G. Clay, M.R. Graham, C.C. Lindsey, K.C. Lamp, C. Freeman, A. Glaros, Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am. J. Geriatr. Pharmacother. 2(3), 181-189 (2004) (Pubitemid 39618443)
126. R. Lobmann, A. Ambrosch, M. Seewald, M. Dietlein, K. Zink, K.H. Kullmann, H. Lehnert, Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones. Diabetes Nutr. Metab. 17(3), 156-162 (2004) (Pubitemid 39117276)
127. R.W. Bradsher Jr, R.M. Snow, Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen. Am. J. Med. 77(4), 63-67 (1984) (Pubitemid 15209249)
128. B.A. Lipsky, U. Stoutenburgh, Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J. Antimicrob. Chemother. 55(2), 240-245 (2005) (Pubitemid 40331152)
129. G. Siami, N. Christou, I. Eiseman, K.J. Tack, Clinafloxacin versus piperacillintazobactam in treatment of patients with severe skin and soft tissue infections. Antimicrob. Agents Chemother. 45(2), 525-531 (2001) (Pubitemid 32105290)
130. L. Harkless, J. Boghossian, R. Pollak, W. Caputo, A. Dana, S. Gray, D. Wu, An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg. Infect. (Larchmt.) 6(1), 27-40 (2005) (Pubitemid 40711363)
131. G.J. Noel, K. Bush, P. Bagchi, J. Ianus, R.S. Strauss, A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin. Infect. Dis. 46(5), 647-655 (2008) (Pubitemid 351321545)
132. R. Vick-Fragoso, G. Hernández-Oliva, J. Cruz-Alcázar, C.F. Amábile-Cuevas, P. Arvis, P. Reimnitz, J.R. Bogner, STIC Study Group, Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 37(5), 407-417 (2009)
133. B.L. Erstad, J. McIntyre, Prospective, randomized comparison of ampicillin/sulbactam and cefoxitin for diabetic foot infections. Vasc. Surg. 31(4), 419-426 (1997) (Pubitemid 27315361)
134. B.A. Lipsky, P.D. Baker, G.C. Landon, R. Fernau, Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin. Infect. Dis. 24(4), 643-648 (1997) (Pubitemid 27143558)
135. B.A. Lipsky, K. Itani, C. Norden, Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillinsulbactam/amoxicillin-clavulanate. Clin. Infect. Dis. 38(1), 17-24 (2004) (Pubitemid 38045868)
136. B.A. Lipsky, P. Giordano, S. Choudhri, J. Song, Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillintazobactam/amoxicillinclavulanate. J. Antimicrob. Chemother. 60(2), 370-376 (2007) (Pubitemid 47243888)
137. M.L. Grayson, G.W. Gibbons, G.M. Habershaw, D.V. Freeman, F.B. Pomposelli, B.I. Rosenblum, E. Levin, A.W. Karchmer, Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin. Infect. Dis. 18(5), 683-693 (1994) (Pubitemid 24145900)
138. Dutch Cochrane Centre (2011), http://www.cochrane.nl/. 8/4/2011
139. A. Yönem, B. Cakir, S. Guler, O.O. Azal, A. Corakci, Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes. Metab. 3(5), 332-337 (2001) (Pubitemid 33076727)
140. F. de Lalla, G. Pellizzer, M. Strazzabosco, Z. Martini, J.G. Du, L. Lora, P. Fabris, P. Benedetti, G. Erle, Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limbthreatening diabetic foot infection. Antimicrob. Agents Chemother. 45(4), 1094-1098 (2001) (Pubitemid 32230987)
141. T. Kästenbauer, B. Hornlein, G. Sokol, K. Irsigler, Evaluation of granulocytecolony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia 46(1), 27-30 (2003) (Pubitemid 36237743)
142. A. Gough, M. Clapperton, N. Rolando, A.V. Foster, J. Philpott-Howard, M.E. Edmonds, Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 350(9081), 855-859 (1997) (Pubitemid 27404347)
143. M. Cruciani, B.A. Lipsky, C. Mengoli, F. de Lalla, Granulocytecolony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst. Rev. 8(3), CD006810 (2009)
144. E. Faglia, G. Clerici, M. Caminiti, A. Quarantiello, M. Gino, A. Morabito, The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes. J. Foot Ankle Surg. 45(4), 220-226 (2006) (Pubitemid 43963536)
145. E. Senneville, A. Lombart, E. Beltrand, M. Valette, L. Legout, M. Cazaubiel, Y. Yazdanpanah, P. Fontaine, Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 31(4), 637-642 (2008)
146. K.Z. Vardakas, M. Horianopoulou, M.E. Falagas, Factors associated with treatment failure in patients diabetic foot infections: an analysis of data from randomised controlled trials. Diabetes Res. Clin. Pract. 80, 344-351 (2008)
147. M.G. Sheahan, A.D. Hamdan, J.R. Veraldi, C.S. McArthur, J.J. Skillman, D.R. Campbell et al., Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J. Vasc. Surg. 42, 476-480 (2005) (Pubitemid 41323835)
148. P.A. Stone, M.R. Back, P.A. Armstrong, S.K. Flaherty, W.B. Keeling, B.L. Johnson, M.L. Shames, D.F. Bandyk, Midfoot amputations expand limb salvage rates for diabetic foot infections. Ann. Vasc. Surg. 19(6), 805-811 (2005) (Pubitemid 41570052)
149. W.J. Jeffcoate, S.Y. Chipchase, P. Ince, F.L. Game, Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29, 1784-1787 (2006) (Pubitemid 44156630)
150. M.J. Young, J.E. McCardle, L.E. Randall, J.I. Barclay, Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care 31, 2143-2147 (2008)
151. J. Edwards, S. Stapley, Debridement of diabetic foot ulcers. Cochrane Database Syst. Rev. (1), CD003556 (2010). doi: 10.1002/14651858
152. F. Game, The advantages and disadvantages of non-surgical management of the diabetic foot. Diabetes Metab. Res. Rev. 24(Suppl 1), S72-S75 (2008) (Pubitemid 351802775)
153. R. Sibbald, K. Woo, The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab. Res. Rev. 24(Suppl 1), S25-S30 (2008) (Pubitemid 351802768)
154. S.M. Bergin, P. Wraight, Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst. Rev. (1), CD005082 (2006)
155. D.G. Armstrong, Diabetic Foot Study Consortium, Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366, 1704-1710 (2005) (Pubitemid 41587449)
156. M.T. Eginton, K.R. Brown, G.R. Seabrook, J.B. Towne, R.A. Cambria, A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann. Vasc. Surg. 17, 645-649 (2003) (Pubitemid 37553487)
157. A. Etöz, Y. Özgenel, M. Özcan, The use of negative pressure wound therapy on diabetic foot ulcers: a preliminary controlled trial. Wounds 16, 264-269 (2004) (Pubitemid 39207820)
158. S.K. McCallon, C.A. Knight, J.P. Valiulus, M.W. Cunningham, J.M. McCulloch, L.P. Farinas, Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage. 46, 28-34 (2000)
159. P.A. Blume, J. Walters, W. Payne, J. Ayala, J. Lantis, Comparison of negative pressure wound therapy using vacuumassisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers. Diabetes Care 31, 631-636 (2008)
160. P. Vikatmaa, V. Juutilainen, P. Kuukasjärvi, A. Malmivaara, Negative pressure wound therapy: a systematic review on effectiveness and safety. Eur. J. Vasc. Endovasc. Surg. 36, 438-448 (2008)
161. E. Faglia, F. Favales, A. Aldeghi, P. Calia, A. Quarantiello, G. Oriani et al., Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 19, 1338-1343 (1996) (Pubitemid 26418611)
162. A. Abidia, G. Laden, G. Kuhan, B.F. Johnson, A.R. Wilkinson, P.M. Renwick et al., The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur. J. Vasc. Endovasc. Surg. 25, 513-518 (2003) (Pubitemid 36701789)
163. N. Doctor, S. Pandya, A. Supe, Hyperbaric oxygen therapy in diabetic foot. J. Postgrad. Med. 38, 112-114 (1992)
164. G. Baroni, T. Porro, E. Faglia, G. Pizzi, A. Mastropasqua, G. Oriani et al., Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 10, 81-86 (1987) (Pubitemid 17069073)
165. W.A. Zamboni, H.P. Wong, L.L. Stephenson, M.A. Pfeifer, Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb. Med. 24, 175-179 (1997) (Pubitemid 127460661)
166. M. Kalani, G. Jörneskog, N. Naderi, F. Lind, K. Brismar, Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J. Diabetes Complicat. 16, 153-158 (2002) (Pubitemid 34224118)
167. M. Löndahl, P. Katzman, A. Nilsson, C. Hammarlund, Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 33, 998-1003 (2010)
168. T. Tan, E.J. Shaw, F. Siddiqui, P. Kandaswamy, P.W. Barry, Guideline Development Group, Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 342, 702-703 (2011)
169. R. van Deursen, Footwear for the neuropathic patient: offloading and stability. Diabetes Metab. Res. Rev. 24(Suppl 1), S96-S100 (2008)
170. S.A. Bus, G.D. Valk, R.W. van Deursen, D.G. Armstrong, C. Caravaggi, P. Hlavácek et al., The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab. Res. Rev. 24(Suppl 1), S162-S180 (2008) (Pubitemid 351802787)
171. P.R. Cavanagh, S.A. Bus, Off-loading the diabetic foot for ulcer prevention and healing. J. Vasc. Surg. 52(3 Suppl), 37S-43S (2010)
172. T.M. Owings, J. Apelqvist, A. Stenström, M. Becker, S. Bus, A. Kalpen, J.S. Ulbrecht, P. Cavanagh, Plantar pressures in diabetic foot ulcer patients who have remained healed. Diabet. Med. 26(11), 1141-1146 (2009)
173. I.A. Katz, A. Harlan, B. Miranda-Palma, L. Prieto-Sanchez, D.G. Armstrong, J.H. Bowker et al., A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 28, 555-559 (2005) (Pubitemid 40315312)
174. D.G. Armstrong, L.A. Lavery, S. Wu, A.J. Boulton, Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 28, 551-554 (2005) (Pubitemid 40326230)
175. P.A. Blume, L.K. Paragas, B.E. Sumpio, C.E. Attinger, Singlestage surgical treatment of noninfected diabetic foot ulcers. Plast. Reconstr. Surg. 109, 601-609 (2002) (Pubitemid 34118428)
176. C.E. Attinger, I. Ducic, P. Cooper, C.M. Zelen, The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients. Plast. Reconstr. Surg. 110, 1047-1054 (2002) (Pubitemid 34913341)
177. A. Piaggesi, E. Schipani, F. Campi, M. Romanelli, F. Baccetti, C. Arvia et al., Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet. Med. 15, 412-417 (1998) (Pubitemid 28197110)
178. E.J. Fitzgerald O'Connor, M. Vesely, P.J. Holt, K.G. Jones, M.M. Thompson, R.J. Hinchliffe, A systematic review of free tissue transfer in the management of non-traumatic lower extremity wounds in patients with diabetes. Eur. J. Vasc. Endovasc. Surg. 41(3), 391-399 (2011)
179. E. Tukiainen, M. Kallio, M. Lepantalo, Advanced leg salvage of the critically ischemic leg with major tissue loss by vascular and plastic surgeon teamwork: long-term outcome. Ann. Surg. 244, 949-957 (2006) (Pubitemid 44808632)
180. C. Randon, F. Vermassen, B. Jacobs, F. De Ryck, K. Van Landuyt, Y. Taes, Outcome of arterial reconstruction and freeflap coverage in diabetic foot ulcers: long-term results. World J. Surg. 34(1), 177-184 (2010)
181. M.J. Mueller, D.R. Sinacore, M.K. Hastings, M.J. Strube, J.E. Johnson, Effect of Achilles tendon lengthening on neuropatic plantar ulcers. A randomized clinical trial. J. Bone Joint Surg. Am. 85A, 1436-1445 (2003) (Pubitemid 36951126)
182. N.L. Petrova, M.E. Edmonds, Charcot neuro-osteoarthropathy- current standards. Diabetes Metab. Res. Rev. 24(Suppl 1), S58-S61 (2008)
183. H. Svensson, J. Larsson, J. Apelqvist, M. Eneroth, Minor amputations successful in patients with diabetes mellitus and severe foot ulcers threatening the survival of the foot. J. Wound Care 20, 261-2, 264, 266 (2011)
184. V. Dargis, O. Pantelejeva, A. Jonushaite, A. Boulton, I. Vileikyte, Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 22(9), 1428-1431 (1999) (Pubitemid 29418234)
185. C.J. McCabe, R.C. Stevenson, A.M. Dolan, Evaluation of diabetic foot screening and protection programme. Diabetes Med. 15, 80-84 (1998) (Pubitemid 28114003)
186. J. Larsson, C.D. Agardh, J. Apelqvist, A. Stenström, Long term prognosis after amputation in diabetic patients. Clin. Orthop. Relat. Res. 350, 149-158 (1998) (Pubitemid 28228269)